GlassScriptPhysician profile
Emanuel A Shapera
NPI 1407268790
$24,076.47
in general payments reported to CMS, 2019-2025
19 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $152 · 2021: $341 · 2022: $6,666 · 2023: $13K · 2024: $2,930 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $2,064 · Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,500.00 |
| Travel and Lodging | $2,063.65 |
| Food and Beverage | $1,099.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,171.63 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Histosonics, INC. | $897.41 | 2025 | |
| Angiodynamics, INC. | $520.25 | 2021-2023 | Nanoknife |
| Enterra Medical, INC. | $207.95 | 2024 | |
| Biom'Up France Sas | $182.00 | 2021 | |
| Ethicon US, LLC | $158.95 | 2019-2025 | |
| Covidien LP | $151.91 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $151.58 | 2023-2025 | Gattex, Entyvio |
| Stryker Corporation | $141.85 | 2022 | |
| W. L. Gore & Associates, INC. | $128.49 | 2019 | |
| Medtronic, INC. | $125.12 | 2022 | |
| Genzyme Corporation | $59.80 | 2024-2025 | |
| Abbvie INC. | $44.69 | 2024 | |
| Madrigal Pharmaceuticals | $35.38 | 2025 | Rezdiffra |
| Vivus LLC | $24.96 | 2025 | Qsymia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $21.63 | 2025 | Rebyota |
| Janssen Biotech, INC. | $20.44 | 2025 | Tremfya, Simponi Aria, Simponi |
| Evoke Pharma, INC. | $19.19 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emanuel Shapera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.